CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	25,236	17,667	13,850	-	-	-
Market Cap Growth	51.12%	27.55%	-	-	-	-
Enterprise Value	29,367	21,380	18,900	-	-	-
Last Close Price	58.74	39.92	31.20	-	-	-
PE Ratio	-	-	179.88	-	-	-
PS Ratio	-	1.70	1.39	-	-	-
PB Ratio	-	2.16	1.60	-	-	-
P/FCF Ratio	-	70.11	-	-	-	-
P/OCF Ratio	-	26.93	38.26	-	-	-
EV/Sales Ratio	-	2.06	1.89	-	-	-
EV/EBITDA Ratio	-	29.13	23.80	-	-	-
EV/EBIT Ratio	-	69.64	50.40	-	-	-
EV/FCF Ratio	-	84.84	-	-	-	-
Debt / Equity Ratio	-	0.60	0.53	0.48	0.61	0.69
Debt / EBITDA Ratio	-	6.09	5.42	2.47	2.62	3.54
Debt / FCF Ratio	-	19.32	-	4.43	4.75	6.07
Asset Turnover	-	0.53	0.54	0.53	0.55	-
Inventory Turnover	-	1.99	2.25	2.39	2.33	-
Quick Ratio	-	0.76	0.82	0.47	0.41	0.35
Current Ratio	-	1.24	1.33	0.76	0.67	0.62
Return on Equity (ROE)	-	0.01%	0.92%	10.05%	11.46%	-
Return on Assets (ROA)	-	0.98%	1.27%	4.41%	4.91%	-
Return on Capital (ROIC)	-	1.46%	1.79%	5.95%	6.67%	-
Return on Capital Employed (ROCE)	-	2.30%	2.70%	12.80%	15.20%	9.10%
Earnings Yield	-	-	0.56%	-	-	-
FCF Yield	-	1.43%	-0.01%	-	-	-
Dividend Yield	1.02%	1.66%	1.71%	-	-	-
Buyback Yield / Dilution	-0.76%	-0.65%	-0.30%	-	-	-
Total Shareholder Return	0.26%	1.01%	1.41%	-	-	-

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.